Indolylmaleimide derivatives as protein kinase C inhibitors

Details for Australian Patent Application No. 2005202387 (hide)

Owner Novartis AG

Inventors Wagner, Jurgen; Albert, Rainer; Sedrani, Richard; Von Matt, Peter; Zenke, Gerhard; Ehrhardt, Claus; Cottens, Sylvain; Evenou, Jean-Pierre; Cooke, Nigel Graham

Agent Davies Collison Cave

Pub. Number AU-B-2005202387

Parent 2002221810

Filing date 1 June 2005

Wipo publication date 23 June 2005

Acceptance publication date 26 March 2009

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/404 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

16 June 2005 Complete Application Filed

23 June 2005 Application Open to Public Inspection

  Published as AU-B-2005202387

26 March 2009 Application Accepted

  Published as AU-B-2005202387

23 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202388-Fluid flow regulator

2005202386-Recombinant influenza viruses for vaccines and gene therapy